Search Results

You are looking at 1 - 10 of 115 items for

  • Author: Margaret Tempero x
  • Refine by Access: All x
Clear All Modify Search
Full access

Margaret Tempero

Full access

Margaret Tempero

Full access

Margaret Tempero

Full access

Margaret Tempero

Full access

Margaret A. Tempero

Pancreatic cancer remains a vexing treatment challenge, with a cure rate that remains just 7%. Two effective regimens—gemcitabine/nab-paclitaxel and FOLFIRINOX—have improved outcomes and are being used earlier in the disease. However, meaningful differences in outcomes may not be realized without novel strategies. Targeting of the immune system is an active area of research.

Full access

Margaret Tempero

Full access

Margaret Tempero

Full access

Margaret Tempero

Full access

Margaret Tempero